支气管扩张症的中西医研究进展

Research Progress on Bronchiectasis in Traditional Chinese and Western Medicine

摘要: 支气管扩张症(简称“支扩”)是由多种病因引起的支气管结构破坏，致使支气管异常和持久性扩张的慢性呼吸系统疾病，大部分患者易合并感染，病情易反复发作，不仅进一步损害病人的肺功能和肺组织，同样在一定程度上影响了病人的生活质量。目前，西医以对症治疗为主，如抗炎、祛痰等，虽然治疗效果确切，但毒副作用较多，并且容易复发。与之相比，中医治疗在调节整体健康、改善机体体质、减少症状急性发作方面独具优势。本文对近几年相关文献进行梳理，系统阐述中西医治疗支扩的研究进展，为开展进一步研究提供参考。

Abstract: Bronchiectasis (BE) is a chronic respiratory disease characterized by permanent, abnormal dilation of the bronchi due to structural destruction from various etiologies. Most patients are prone to recurrent infections and frequent exacerbations, which progressively impair lung function and compromise pulmonary architecture, significantly reducing quality of life. Current Western medical management primarily focuses on symptomatic treatment, including anti-inflammatory therapy and expectorants. Although effective in alleviating acute symptoms, these interventions are often associated with considerable adverse effects and a high recurrence rate. In contrast, Traditional Chinese Medicine (TCM) emphasizes holistic regulation and constitutional improvement, demonstrating distinctive advantages in reducing acute exacerbations, enhancing systemic conditioning, and stabilizing long-term outcomes. This article reviews recent literature to systematically summarize advances in the integrated treatment of bronchiectasis using both Western and traditional Chinese medical approaches. It aims to provide a reference for further clinical research and evidence-based practice.